OBJECTIVE: Evaluate changes in end-of-life care following initiation of a palliative care program in a neonatal intensive care unit. STUDY DESIGN: Retrospective study comparing infant deaths before and after implementation of a Palliative Care Program comprised of medication guidelines, an individualized order set, a nursing care plan and staff education. RESULT: Eighty-two infants died before (Era 1) and 68 infants died after implementation of the program (Era 2). Morphine use was similar (88% vs 81%; P =0.17), whereas benzodiazepines use increased in Era 2 (26% vs 43%; P=0.03). Withdrawal of life support (73% vs 63%; P=0.17) and do-not-resuscitate orders (46% vs 53%; P=0.42) were similar. Do-not-resuscitate orders and family meetings were more frequent among Era 2 infants with activated palliative care orders (n=21) compared with infants without activated orders (n=47). CONCLUSION: End-of-life family meetings and benzodiazepine use increased following implementation of our program, likely reflecting adherence to guidelines and improved communication.
OBJECTIVE: Evaluate changes in end-of-life care following initiation of a palliative care program in a neonatal intensive care unit. STUDY DESIGN: Retrospective study comparing infant deaths before and after implementation of a Palliative Care Program comprised of medication guidelines, an individualized order set, a nursing care plan and staff education. RESULT: Eighty-two infants died before (Era 1) and 68 infants died after implementation of the program (Era 2). Morphine use was similar (88% vs 81%; P =0.17), whereas benzodiazepines use increased in Era 2 (26% vs 43%; P=0.03). Withdrawal of life support (73% vs 63%; P=0.17) and do-not-resuscitate orders (46% vs 53%; P=0.42) were similar. Do-not-resuscitate orders and family meetings were more frequent among Era 2 infants with activated palliative care orders (n=21) compared with infants without activated orders (n=47). CONCLUSION: End-of-life family meetings and benzodiazepine use increased following implementation of our program, likely reflecting adherence to guidelines and improved communication.
Authors: Annie Janvier; William Meadow; Steven R Leuthner; Bree Andrews; Joanne Lagatta; Arend Bos; Laura Lane; A A Eduard Verhagen Journal: J Pediatr Date: 2011-02-26 Impact factor: 4.406
Authors: Jeannie D Chan; Patsy D Treece; Ruth A Engelberg; Lauren Crowley; Gordon D Rubenfeld; Kenneth P Steinberg; J Randall Curtis Journal: Chest Date: 2004-07 Impact factor: 9.410
Authors: Daphna Gans; Gerald F Kominski; Dylan H Roby; Allison L Diamant; Xiao Chen; Wenjiao Lin; Nina Hohe Journal: Policy Brief UCLA Cent Health Policy Res Date: 2012-08
Authors: Marissa C Michel; Tarah T Colaizy; Jonathan M Klein; Jeffrey L Segar; Edward F Bell Journal: Pediatr Res Date: 2018-02-14 Impact factor: 3.756
Authors: Sue L Hall; Mobolaji E Famuyide; Sage N Saxton; Tiffany A Moore; Sara Mosher; Keira Sorrells; Cheryl A Milford; Jenene Craig Journal: Adv Neonatal Care Date: 2019-12 Impact factor: 1.968